Shanghai Leadingtac Pharmaceutical Co., Ltd.
PrivateLast Round
Series B
Dec 18, 2025
Total Funding Raised
$42M
Momentum Score
25 /100
Company Overview
Shanghai Leadingtac Pharmaceutical Co., Ltd. is a biotechnology company that develops small-molecule innovative drugs focused on targeted protein degradation for the treatment of autoimmunity and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 18, 2025 | ||||
| Series A | Nov 18, 2024 | ||||
| Pre Seed | Nov 8, 2021 | ||||
| Angel | Nov 1, 2019 |
Shanghai Leadingtac Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Kangcheng Investment Management Co., Ltd. | Series B |
| YuanBio Venture Capital | Pre Seed |
| Lapam Capital | Series B, Series A |
| Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. | Series A |
| 湖南天瑞丰年私募股权基金管理有限公司 | Series A |
| CDH VGC | Series B |
| Hankang Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 1074% MoM.
- Jan 6, 2026
Monthly visitors increased 230% MoM.
Shanghai Leadingtac Pharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Leadingtac Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
